Synaptogenix Balance Sheet Health

Financial Health criteria checks 6/6

Synaptogenix has a total shareholder equity of $25.6M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $31.1M and $5.5M respectively.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ration/a
CashUS$30.10m
EquityUS$25.58m
Total liabilitiesUS$5.53m
Total assetsUS$31.11m

Recent financial health updates

Recent updates

We Think Synaptogenix (NASDAQ:SNPX) Can Afford To Drive Business Growth

Sep 20
We Think Synaptogenix (NASDAQ:SNPX) Can Afford To Drive Business Growth

Companies Like Synaptogenix (NASDAQ:SNPX) Are In A Position To Invest In Growth

May 10
Companies Like Synaptogenix (NASDAQ:SNPX) Are In A Position To Invest In Growth

Synaptogenix: High-Risk High-Reward For Potential Alzheimer's Disease Treatment

Nov 17

Synaptogenix (NASDAQ:SNPX) Is In A Good Position To Deliver On Growth Plans

Oct 05
Synaptogenix (NASDAQ:SNPX) Is In A Good Position To Deliver On Growth Plans

Synaptogenix: The Next Big Thing In Alzheimer's

Jun 16

Synaptogenix provides update on phase 2b Alzheimer's disease trial

Jun 09

We're Keeping An Eye On Synaptogenix's (NASDAQ:SNPX) Cash Burn Rate

Jun 09
We're Keeping An Eye On Synaptogenix's (NASDAQ:SNPX) Cash Burn Rate

Financial Position Analysis

Short Term Liabilities: SNPX's short term assets ($30.5M) exceed its short term liabilities ($4.3M).

Long Term Liabilities: SNPX's short term assets ($30.5M) exceed its long term liabilities ($1.3M).


Debt to Equity History and Analysis

Debt Level: SNPX is debt free.

Reducing Debt: SNPX has not had any debt for past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: SNPX has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: SNPX has sufficient cash runway for more than 3 years if free cash flow continues to grow at historical rates of 7.9% each year


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.